2 results
Approved WMOCompleted
To study the underlying demographic, clinical and pharmacogenetic factors contributing to the failure of achieving analgesia and/or the occurrence of dose-limiting side effects in individual cancer patients for seperate opioids;- To study if theā¦
Approved WMOWill not start
To assess the safety and reactogenicity of HB-101.To assess the immunogenicity of HB-101.